Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05RKV
|
||||
Former ID |
DIB012716
|
||||
Drug Name |
Sch-036
|
||||
Synonyms |
Cannabinoid CB2 inverse agonists (immune disorders); Sch-036; Cannabinoid CB2 inverse agonists (immune disorders), Schering-Plough
|
||||
Indication | Immune disorder [ICD10:D80-D89] | Investigative | [543878] | ||
Company |
Schering-Plough Research Institute
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
O=S(=O)(C(F)(F)F)NCC1(CCN(S(=O)(=O)c2n(S(=O)(=O)c3ncccc<br />3)c3ccccc3c2)CC1)CCC
|
||||
Target and Pathway | |||||
Target(s) | Cannabinoid receptor 2 | Target Info | Agonist | [543878] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.